Skip to content Blue Heron Capital
Contact Call
  • Home
  • Approach
  • Community
  • Experience
  • Partnership
  • In the News
  • Contact
  • Investor Login

Archives

  • January 2023
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • April 2022
  • March 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • August 2021
  • June 2021
  • February 2021
  • December 2020
  • August 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • July 2018
  • February 2018
  • December 2017
  • October 2017
  • August 2017
  • July 2017
  • January 2017
  • October 2016
  • September 2016
  • July 2016
  • June 2016
  • October 2015
  • August 2015
  • April 2014
  • Archive

    VIDA CEO Susan Wood Presents at the LSI Emerging Medtech Summit

    April 22, 2022

    VIDA CEO Susan Wood presents at the LSI Emerging Medtech Summit to explain how the lung has been underfunded because lung trials are slow and very costly which disincentives investment. VIDA’s intelligence solution blocks these barriers.

    Read More

    VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence

    December 2, 2021

    VIDA is further removing friction in respiratory clinical trials with the introduction of a new AI-powered portal.

    Read More

    VIDA appoints digital health technology leader Karen Drexler to board of directors

    August 11, 2020

    Growing bench of proven leaders in clinical lung intelligence and health technology bolsters both product and commercial advances CORALVILLE, Iowa, Aug. 11, 2020 /PRNewswire/ — VIDA Diagnostics, Inc.

    Read More

    15 Companies That Are Saving The World From Covid-19

    June 25, 2020

    In the wake of the Covid-19 pandemic we all can feel lost, helpless and bereft of hope at times. We turn on the news to see conflicting “experts” telling us to do opposite things for the sake of our health and the public’s health.

    Read More

    VIDA’s CEO named in the Top 50 Healthcare Technology CEOs of 2020

    May 19, 2020

    The Healthcare Technology Report is pleased to announce The Top 50 Healthcare Technology CEOs of 2020. Now more than ever, with our global community impacted by a severe pandemic, the importance of the healthcare technology field is at the forefront.

    Read More

    Blue Heron Announces Investment in VIDA

    March 24, 2020

    Blue Heron Capital Invests in Leading AI-Powered Lung Imaging Analysis Technology Blue Heron Capital, a Richmond, Virginia-based growth equity fund, announced today its participation in an $11 million investment round in VIDA Diagnostics, Inc.

    Read More
    • Home
    • Approach
    • Community
    • Experience
    • Partnership
    • In the News
    • Contact

    804-212-3400 | 1519 Summit Avenue, Suite 200 Richmond, VA 23230

    All Rights Reserved. Blue Heron Capital. Copyright 2023

    Privacy Policy Sitemap
    This site uses cookies: Find out more.